T-BUTYLISOTHIOCYANATE

[ Density]:
0.9±0.1 g/cm3

[ Boiling Point ]:
141.6±0.0 °C at 760 mmHg

[ Melting Point ]:
8-11 °C

[ Molecular Formula ]:
C₅H₉NS

[ Molecular Weight ]:
115.197

[ Flash Point ]:
38.3±0.0 °C

[ Exact Mass ]:
115.045570

[ PSA ]:
44.45000

[ LogP ]:
2.17

[ Vapour Pressure ]:
7.3±0.2 mmHg at 25°C

[ Index of Refraction ]:
1.471

[ Storage condition ]:
Flammables area

Click to get detail MSDS

[ Symbol ]:

GHS02, GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H226-H301 + H311 + H331-H319-H335

[ Precautionary Statements ]:
P261-P280-P301 + P310-P305 + P351 + P338-P311

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
T

[ Risk Phrases ]:
R34

[ Safety Phrases ]:
S45-S38-S36/37/39-S28A-S26-S16-S27

[ RIDADR ]:
2929

[ Packaging Group ]:
II

[ Hazard Class ]:
6.1

[ HS Code ]:
2930909090

Click to get detail synthetic route

Precursor

DownStream

[ HS Code ]: 2930909090

[ Summary ]:
2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.

Curr. Drug Metab. 6 , 413-54, (2005)

The inhibition of human cytochrome P450s (CYPs) is one of the most common mechanisms which can lead to drug-drug interactions. The inhibition of CYPs can be reversible (competitive or non-competitive)...

Programmed functionalization of SURMOFs via liquid phase heteroepitaxial growth and post-synthetic modification.

Dalton Trans. 42(45) , 16029-35, (2013)

Heterostructured surface mounted metal-organic frameworks (SURMOFs) [Cu2(NH2-bdc)2(dabco)] (B) on top of [Cu2(bdc)2(dabco)] (A) were deposited on pyridyl-terminated Au covered QCM substrate using a st...

Reaction of tert -butyl isocyanate and tert-butyl isothiocyanate at the Ge (100)- 2× 1 Surface. Loscutoff PW, et al.

Surface Science 604(19) , 1791-99, (2010)

More Articles